Pfizer to pay $330M in Prempro settlement

Bloomberg is reporting that Pfizer has agreed to settle lawsuits over its menopause drug for $330 million. The drugmaker inherited 2,200 lawsuits claiming that Prempro caused breast cancer when it acquired Wyeth in 2009. Each case will settle for an average of $150,000.

More than 6 million women took the hormone-replacement drug to treat menopause symptoms, which include mood swings and hot flashes. But sales of the blockbuster fell after a 2002 study linked Prempro and similar drugs to an increased risk of breast cancer. Prempro is still on the market.

Analyst Les Funtleyder of Miller Tabak & Co. said the settlement talks could be a sign the company's new management is looking to eliminate litigation that's been dragging on for year. But the drugmaker refused to confirm the settlement rumors. "The reported settlement terms are not accurate and beyond that, we do not comment on our litigation strategy," a spokesperson told Bloomberg.

- here's the Bloomberg report

Special Report: Big Pharma behaving badly: A timeline of settlements


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.